Optimization of an in vitro chemotherapy to avoid resistant tumours
- PMID: 27864095
- DOI: 10.1016/j.jtbi.2016.11.009
Optimization of an in vitro chemotherapy to avoid resistant tumours
Abstract
Chemotherapy use against solid tumours often results in the resistance of the cancer cells to the molecule used. In this paper, we will set up and analyse an ODE model for heterogeneous in vitro tumours, consisting of cells that are sensitive or resistant to a certain drug. We will then use this model to develop different protocols, that aim at reducing the tumour volume while preserving its heterogeneity. These drug administration schedules are determined through analysis of the system dynamics, and optimal control theory.
Keywords: Chemotherapy; Mathematical model; Metronomics; Optimal control.
Copyright © 2016 Elsevier Ltd. All rights reserved.
Similar articles
-
Modeling the chemotherapy-induced selection of drug-resistant traits during tumor growth.J Theor Biol. 2018 Jan 7;436:120-134. doi: 10.1016/j.jtbi.2017.10.005. Epub 2017 Oct 13. J Theor Biol. 2018. PMID: 29030212
-
On drug resistance and metronomic chemotherapy: A mathematical modeling and optimal control approach.Math Biosci Eng. 2017 Feb 1;14(1):217-235. doi: 10.3934/mbe.2017014. Math Biosci Eng. 2017. PMID: 27879129
-
Modeling drug resistance in a conjoint normal-tumor setting.Theor Biol Med Model. 2015 Jan 15;12:3. doi: 10.1186/1742-4682-12-3. Theor Biol Med Model. 2015. PMID: 25588472 Free PMC article.
-
Application of mathematical models to metronomic chemotherapy: What can be inferred from minimal parameterized models?Cancer Lett. 2017 Aug 10;401:74-80. doi: 10.1016/j.canlet.2017.03.021. Epub 2017 Mar 18. Cancer Lett. 2017. PMID: 28323033 Review.
-
Cell population heterogeneity and evolution towards drug resistance in cancer: Biological and mathematical assessment, theoretical treatment optimisation.Biochim Biophys Acta. 2016 Nov;1860(11 Pt B):2627-45. doi: 10.1016/j.bbagen.2016.06.009. Epub 2016 Jun 20. Biochim Biophys Acta. 2016. PMID: 27339473 Review.
Cited by
-
Optimizing adaptive cancer therapy: dynamic programming and evolutionary game theory.Proc Biol Sci. 2020 Apr 29;287(1925):20192454. doi: 10.1098/rspb.2019.2454. Epub 2020 Apr 22. Proc Biol Sci. 2020. PMID: 32315588 Free PMC article.
-
Modeling cancer's ecological and evolutionary dynamics.Med Oncol. 2023 Feb 28;40(4):109. doi: 10.1007/s12032-023-01968-0. Med Oncol. 2023. PMID: 36853375 Free PMC article.
-
A survey of open questions in adaptive therapy: Bridging mathematics and clinical translation.Elife. 2023 Mar 23;12:e84263. doi: 10.7554/eLife.84263. Elife. 2023. PMID: 36952376 Free PMC article.
-
Effective dose window for containing tumor burden under tolerable level.NPJ Syst Biol Appl. 2023 May 23;9(1):17. doi: 10.1038/s41540-023-00279-4. NPJ Syst Biol Appl. 2023. PMID: 37221258 Free PMC article.
-
The Contribution of Evolutionary Game Theory to Understanding and Treating Cancer.Dyn Games Appl. 2022;12(2):313-342. doi: 10.1007/s13235-021-00397-w. Epub 2021 Aug 30. Dyn Games Appl. 2022. PMID: 35601872 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources